CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Fresenius Medical Care AG & Co KGaA - FME CFD

39.36
1.16%
0.13
Low: 38.43
High: 39.49
Market Trading Hours* (UTC) Open now
Closes on Friday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.019277 %
Charges from borrowed part ($-0.77)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.019277%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.002946 %
Charges from borrowed part ($-0.12)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.002946%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 20%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Fresenius Medical Care AG & Co KGaA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 38.82
Open* 38.64
1-Year Change* -35.47%
Day's Range* 38.43 - 39.49
52 wk Range 25.95-63.66
Average Volume (10 days) 1.14M
Average Volume (3 months) 17.41M
Market Cap 11.40B
P/E Ratio 16.92
Shares Outstanding 293.41M
Revenue 19.40B
EPS 2.30
Dividend (Yield %) 2.88214
Beta 0.84
Next Earnings Date May 9, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 30, 2023 38.82 0.73 1.92% 38.09 38.87 37.43
Mar 29, 2023 38.10 -0.10 -0.26% 38.20 38.50 37.78
Mar 28, 2023 38.22 -0.15 -0.39% 38.37 38.66 37.65
Mar 27, 2023 38.48 1.00 2.67% 37.48 38.57 37.25
Mar 24, 2023 37.01 -0.58 -1.54% 37.59 37.73 36.32
Mar 23, 2023 37.87 0.54 1.45% 37.33 37.96 37.12
Mar 22, 2023 37.63 0.49 1.32% 37.14 37.95 37.14
Mar 21, 2023 37.03 0.62 1.70% 36.41 37.20 36.26
Mar 20, 2023 36.32 -0.24 -0.66% 36.56 37.14 35.71
Mar 17, 2023 36.52 -0.16 -0.44% 36.68 37.73 35.77
Mar 16, 2023 36.62 -0.31 -0.84% 36.93 37.27 36.34
Mar 15, 2023 36.85 -0.44 -1.18% 37.29 37.46 36.47
Mar 14, 2023 37.16 -0.02 -0.05% 37.18 37.30 36.42
Mar 13, 2023 37.06 0.31 0.84% 36.75 37.51 36.08
Mar 10, 2023 36.99 1.26 3.53% 35.73 36.99 35.65
Mar 9, 2023 36.31 0.29 0.81% 36.02 36.45 35.84
Mar 8, 2023 36.24 0.51 1.43% 35.73 36.25 35.69
Mar 7, 2023 36.06 -0.53 -1.45% 36.59 36.78 35.84
Mar 6, 2023 37.45 0.61 1.66% 36.84 37.71 36.69
Mar 3, 2023 36.50 0.79 2.21% 35.71 36.51 35.67

Fresenius Medical Care AG & Co KGaA Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 19398 17618.7 17859.1 17476.6 16546.9
Revenue 19398 17618.7 17859.1 17476.6 16546.9
Cost of Revenue, Total 14087.8 12541.7 12321.6 12080.7 11392.1
Gross Profit 5310.25 5077.03 5537.44 5395.85 5154.74
Total Operating Expense 17886.3 15766.4 15554.7 15207 13509.1
Selling/General/Admin. Expenses, Total 3528.86 2996.98 3102.8 2939.13 2709.78
Research & Development 218.63 214.345 188.75 164.976 133.274
Depreciation / Amortization 9.994 6.437 5.024 3.052 0.341
Interest Expense (Income) - Net Operating 29.864 -26.024 -115.456 -73.611 -65.408
Unusual Expense (Income) 11.147 33.005 51.92 92.744 -661.043
Operating Income 1511.76 1852.29 2304.41 2269.56 3037.8
Interest Income (Expense), Net Non-Operating -292.476 -280.429 -368.019 -429.444 -301.062
Net Income Before Taxes 1219.28 1571.86 1936.39 1840.11 2736.74
Net Income After Taxes 894.325 1219.03 1435.83 1438.5 2225.66
Minority Interest -220.92 -249.72 -271.455 -238.881 -243.733
Net Income Before Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Net Income 673.405 969.308 1164.38 1199.62 1981.92
Income Available to Common Excl. Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Income Available to Common Incl. Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Diluted Net Income 673.405 969.308 1164.38 1199.62 1981.92
Diluted Weighted Average Shares 293.246 292.945 294.056 302.691 307.275
Diluted EPS Excluding Extraordinary Items 2.29638 3.30884 3.95972 3.96318 6.45
Dividends per Share - Common Stock Primary Issue 1.12 1.35 1.34 1.2 1.17
Diluted Normalized EPS 3.98317 3.79414 4.71608 4.2027 4.70044
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 4996.8 5096.17 4756.68 4548.37 4647.02
Revenue 4996.8 5096.17 4756.68 4548.37 4647.02
Cost of Revenue, Total 3649.28 3737.58 3410.63 3290.27 3327.86
Gross Profit 1347.52 1358.59 1346.05 1258.09 1319.16
Total Operating Expense 4644.87 4624.52 4416.17 4200.7 4197.87
Selling/General/Admin. Expenses, Total 954.297 989.607 969.489 871.241 823.21
Research & Development 59.237 58.452 53.334 47.607 65.701
Depreciation / Amortization 2.812 3.032 2.084 2.066 2.057
Interest Expense (Income) - Net Operating -19.257 -17.448 -19.367 -10.487 -20.961
Operating Income 351.934 471.643 340.51 347.668 449.155
Interest Income (Expense), Net Non-Operating -75.315 -76.485 -71.579 -69.097 -66.712
Net Income Before Taxes 276.619 395.158 268.931 278.571 382.443
Net Income After Taxes 193.582 282.932 206.005 211.806 303.741
Minority Interest -54.778 -52.832 -58.865 -54.445 -75
Net Income Before Extra. Items 138.804 230.1 147.14 157.361 228.741
Net Income 138.804 230.1 147.14 157.361 228.741
Income Available to Common Excl. Extra. Items 138.804 230.1 147.14 157.361 228.741
Income Available to Common Incl. Extra. Items 138.804 230.1 147.14 157.361 228.741
Diluted Net Income 138.804 230.1 147.14 157.361 228.741
Diluted Weighted Average Shares 293.415 293.413 293.145 293.007 293
Diluted EPS Excluding Extraordinary Items 0.47306 0.78422 0.50194 0.53706 0.78069
Dividends per Share - Common Stock Primary Issue 1.12 0 0 0 1.35
Diluted Normalized EPS 1.47121 0.42868 0.70576 0.64864 1.14933
Unusual Expense (Income) -1.503 -146.699
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 7967.24 7275.31 7165.15 7846.89 6374.31
Cash and Short Term Investments 1618.02 1243.23 1141.05 2265.14 993.574
Cash 925.134 746.851 768.706 831.885 620.145
Cash & Equivalents 556.521 334.688 239.017 1313.75 357.964
Short Term Investments 136.362 161.688 133.322 119.507 15.465
Total Receivables, Net 3769.23 3579.29 3969.26 3765.57 3696.15
Accounts Receivable - Trade, Net 3409.06 3153.04 3421.35 3337.71 3389.33
Total Inventory 2038.01 1895.31 1663.28 1466.8 1290.78
Prepaid Expenses 377.907 374.081 178.474 135.729 124.162
Other Current Assets, Total 164.07 183.398 213.086 213.646 269.64
Total Assets 34366.6 31689 32934.7 26242.3 24025.2
Property/Plant/Equipment, Total - Net 8551.47 8186.75 8515.4 3836.01 3491.77
Property/Plant/Equipment, Total - Gross 16654.3 14830.4 14413.4 8507.4 7655.4
Accumulated Depreciation, Total -8102.86 -6643.68 -5897.98 -4671.39 -4163.63
Goodwill, Net 14361.6 12958.7 14017.3 12209.6 12103.9
Intangibles, Net 1459.39 1381.01 1426.33 681.331 683.058
Long Term Investments 786.905 761.113 696.872 649.78 647.009
Other Long Term Assets, Total 1239.97 1126.12 1113.74 1018.66 725.149
Total Current Liabilities 7257.63 6159.64 7007.23 6268.28 5299.89
Accounts Payable 736.069 731.993 716.526 641.271 590.493
Accrued Expenses 2225.56 2115.75 1964.24 2056.49 2056.18
Notes Payable/Short Term Debt 1255.85 79.27 1171.85 1394.19 769.279
Current Port. of LT Debt/Capital Leases 1329.54 1617.52 2086.16 1244.73 994.731
Other Current Liabilities, Total 1710.61 1615.11 1068.46 931.597 889.211
Total Liabilities 21667.8 20474 20976.8 14483.9 14205.1
Total Long Term Debt 10734.8 10683.2 10524.6 5045.52 5794.87
Long Term Debt 6646.95 6800.1 6458.32 5018.76 5766
Capital Lease Obligations 4087.8 3883.13 4066.3 26.757 28.873
Deferred Income Tax 868.452 785.886 739.702 626.521 467.54
Minority Interest 1280.25 1116.23 1269.32 1143.55 1008.08
Other Liabilities, Total 1526.68 1728.96 1435.95 1399.99 1634.72
Total Equity 12698.8 11215.1 11957.9 11758.4 9820.1
Common Stock 293.004 292.877 304.437 307.879 308.111
Additional Paid-In Capital 2891.28 2872.63 3607.66 3873.34 3969.25
Retained Earnings (Accumulated Deficit) 10826.1 10254.9 9454.86 8831.93 7137.25
Treasury Stock - Common 0 -370.502 -50.993 -108.931
Other Equity, Total -1311.64 -2205.34 -1038.55 -1203.75 -1485.58
Total Liabilities & Shareholders’ Equity 34366.6 31689 32934.7 26242.3 24025.2
Total Common Shares Outstanding 293.004 292.877 298.329 306.879 306.451
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 8039.39 7967.24 7998.91 7814.68 7789.41
Cash and Short Term Investments 1173.34 1481.66 1561.83 1407.96 1073.48
Cash & Equivalents 1173.34 556.521 1561.83 1407.96 1073.48
Total Receivables, Net 3890.82 3571.42 3449.86 3526.45 3894.15
Accounts Receivable - Trade, Net 3707.49 3409.06 3323.6 3419.51 3740.71
Total Inventory 2136.96 2038.01 2119.8 2052.94 1989.41
Other Current Assets, Total 838.272 876.151 867.414 827.332 832.376
Total Assets 34724.1 34366.6 33830.9 32987.2 33158.5
Property/Plant/Equipment, Total - Net 8510.45 8551.47 8391.22 8320.06 8415.64
Goodwill, Net 14628.7 14361.6 13901.4 13495.5 13638.9
Intangibles, Net 1480.42 1459.39 1418.94 1395.03 1401.5
Long Term Investments 798.947 786.905 742.799 708.56 726.595
Other Long Term Assets, Total 1266.2 1239.97 1377.62 1253.37 1186.48
Total Current Liabilities 6377.45 7257.63 7492.3 7424.63 7242.97
Accounts Payable 790.236 736.069 706.385 684.981 635.422
Accrued Expenses 3515.83 3676.88 3885.14 3850.79 3792.75
Notes Payable/Short Term Debt 1115.21 1255.85 1363.29 1385.03 1140.62
Current Port. of LT Debt/Capital Leases 730.959 1329.54 1293.77 1261.47 1423.64
Other Current Liabilities, Total 225.212 259.293 243.715 242.356 250.54
Total Liabilities 21489.6 21667.8 21601.2 21355.3 21160.5
Total Long Term Debt 11497.2 10734.8 10570.1 10469 10336.2
Long Term Debt 7451.79 6646.95 6571.22 6499 6315.27
Capital Lease Obligations 4045.41 4087.8 3998.86 3970.02 4020.95
Deferred Income Tax 896.38 868.452 863.9 800.492 809.215
Minority Interest 1304.8 1280.25 1216.24 1180.48 1201.58
Other Liabilities, Total 1413.8 1526.68 1458.73 1480.62 1570.47
Total Equity 13234.5 12698.8 12229.7 11632 11998.1
Common Stock 293.027 293.004 292.994 292.979 292.888
Additional Paid-In Capital 2891.74 2891.28 2884.96 2886.97 2887.04
Retained Earnings (Accumulated Deficit) 11027.2 10826.1 10567.7 10290.6 10500
Other Equity, Total -977.445 -1311.64 -1515.97 -1838.63 -1681.86
Total Liabilities & Shareholders’ Equity 34724.1 34366.6 33830.9 32987.2 33158.5
Total Common Shares Outstanding 293.027 293.004 292.994 292.979 292.888
Cash 925.134
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 1219.03 1435.83 1438.5 2225.66 1554.53
Cash From Operating Activities 2489.5 4233.16 2566.95 2061.91 2191.81
Cash From Operating Activities 1623.68 1785.9 1593.16 724.847 735.479
Deferred Taxes 67.259 111.104 64.266 89.171 -203.046
Non-Cash Items 232.342 215.137 304.705 -824.73 -126.822
Cash Taxes Paid 345.052 301.663 387.719 358.386 674.625
Cash Interest Paid 341.629 379.994 470.223 311.971 339.088
Changes in Working Capital -652.807 685.184 -833.68 -153.034 231.666
Cash From Investing Activities -1196.23 -1334.94 -3285.99 -245.039 -991.541
Capital Expenditures -886.715 -1085.23 -1162.76 -1142.38 -970.83
Other Investing Cash Flow Items, Total -309.513 -249.709 -2123.22 897.34 -20.711
Cash From Financing Activities -1024.38 -2664.03 -466.633 -681.736 -798.63
Financing Cash Flow Items -279.535 -693.531 153.387 -528.009 -185.979
Total Cash Dividends Paid -392.455 -351.17 -354.636 -324.838 -293.973
Issuance (Retirement) of Stock, Net 6.511 -353.335 -583.932 10.183 -10.347
Issuance (Retirement) of Debt, Net -358.903 -1265.99 318.548 160.928 -308.331
Foreign Exchange Effects 131.228 -160.371 47.76 32.387 -132.413
Net Change in Cash 400.116 73.816 -1137.91 1167.52 269.227
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 211.806 1219.03 915.287 584.052 304.334
Cash From Operating Activities 158.697 2489.5 1820.45 1128.77 207.648
Cash From Operating Activities 418.957 1623.68 1186.57 783.735 388.202
Deferred Taxes -9.295 67.259 -12.828 -36.814 -6.054
Non-Cash Items 54.974 232.342 116.658 91.471 40.292
Cash Taxes Paid 44.301 345.052 268.11 209.901 41.793
Cash Interest Paid 79.484 341.629 255.162 171.384 104.607
Changes in Working Capital -517.745 -652.807 -385.234 -293.674 -519.126
Cash From Investing Activities -211.316 -1196.23 -773.438 -473.178 -224.053
Capital Expenditures -198.313 -854.36 -858.778 -522.335 -290.79
Other Investing Cash Flow Items, Total -13.003 -341.868 85.34 49.157 66.737
Cash From Financing Activities -266.641 -1024.38 -666.849 -378.319 -35.915
Financing Cash Flow Items 464.211 -279.535 -208.996 -133.871 -47.907
Issuance (Retirement) of Stock, Net 0.792 6.511 6.005 5.228 0.575
Issuance (Retirement) of Debt, Net -731.644 -358.903 -71.403 142.779 11.417
Foreign Exchange Effects 10.947 131.228 100.131 49.146 44.259
Net Change in Cash -308.313 400.116 480.295 326.419 -8.061
Total Cash Dividends Paid -392.455 -392.455 -392.455
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fresenius SE & Co KGaA Corporation 32.1663 94380382 0 2023-02-21 LOW
Pzena Investment Management, LLC Investment Advisor/Hedge Fund 5.2 15257499 6433048 2023-01-02 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.105 12044710 1321531 2023-03-17 LOW
Harris Associates L.P. Investment Advisor/Hedge Fund 3.0098 8831173 15678 2023-02-28 LOW
Dodge & Cox Investment Advisor/Hedge Fund 3.0017 8807448 -5315479 2023-01-03 LOW
Artisan Partners Limited Partnership Investment Advisor 2.9941 8785062 0 2023-01-02 LOW
Templeton Investment Counsel, L.L.C. Investment Advisor/Hedge Fund 2.659 7801761 200236 2023-01-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.037 5976971 13981 2023-02-28 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.2147 3564186 -379946 2022-12-31 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.0855 3185091 105743 2023-02-28 LOW
Fidelity International Investment Advisor 0.9623 2823645 47140 2023-01-31 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 0.8519 2499677 -3590 2023-02-28 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5802 1702442 36990 2023-02-28 LOW
Macquarie Investment Management Investment Advisor 0.5594 1641311 -6380 2023-02-28 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 0.5432 1593946 25473 2023-02-28 LOW
Fiduciary Management, Inc. Investment Advisor 0.506 1484650 130000 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.4893 1435667 839 2023-02-28 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4514 1324441 10743 2023-02-28 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.4436 1301694 81837 2023-02-28 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.4212 1235851 0 2023-02-28 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Fresenius Medical Care Company profile

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Fresenius Medical Care AG & Co. KGaA revenues decreased 1% to EUR17.62B. Net income decreased 17% to EUR969M. Revenues reflect Health Care Services decrease of 2% to EUR13.88B, Health Care Products remaining flat at EUR3.74B. Net income also reflects Income from equity method investees decrease of 3% to EUR92M (income). Dividend per share increased from EUR1.34 to EUR1.35.

Equity composition

1/2006, 1-for-1 Complex capital change(Factor: 1). 3/2006, Company name changed from Fresenius Medical Care AG. 06/2007, 3-for-1 stock split.

Industry: Healthcare Facilities & Services (NEC)

Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE

Income Statement

  • Annual
  • Quarterly

News

A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

09:37, 31 March 2023
People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

Singapore's DBS has seen inflows in SVB aftermath, CEO says

DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

09:24, 31 March 2023
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

US STOCKS-Futures muted as investors await key inflation data

U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

09:16, 31 March 2023
A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

09:14, 31 March 2023
A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

Coal India surpasses annual output target for first time in 17 years

Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

09:13, 31 March 2023
A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

Global IPOs marred by banks and recession enjoy few bright spots

A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

09:06, 31 March 2023
A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

UniCredit shareholders gather to vote on CEO's new pay scheme

Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

09:04, 31 March 2023

People also watch

US100

13,022.10 Price
+0.440% 1D Chg, %
Long position overnight fee -0.0249%
Short position overnight fee 0.0027%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

1,979.69 Price
-0.020% 1D Chg, %
Long position overnight fee -0.0180%
Short position overnight fee 0.0098%
Overnight fee time 21:00 (UTC)
Spread 0.30

Oil - Crude

75.22 Price
+1.250% 1D Chg, %
Long position overnight fee -0.0170%
Short position overnight fee -0.0049%
Overnight fee time 21:00 (UTC)
Spread 0.03

Natural Gas

2.20 Price
+4.160% 1D Chg, %
Long position overnight fee -0.4480%
Short position overnight fee 0.4261%
Overnight fee time 21:00 (UTC)
Spread 0.006

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading